JP2017131682A5 - - Google Patents

Download PDF

Info

Publication number
JP2017131682A5
JP2017131682A5 JP2017050041A JP2017050041A JP2017131682A5 JP 2017131682 A5 JP2017131682 A5 JP 2017131682A5 JP 2017050041 A JP2017050041 A JP 2017050041A JP 2017050041 A JP2017050041 A JP 2017050041A JP 2017131682 A5 JP2017131682 A5 JP 2017131682A5
Authority
JP
Japan
Prior art keywords
cells
hours
liver
found
control
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017050041A
Other languages
English (en)
Japanese (ja)
Other versions
JP6891010B2 (ja
JP2017131682A (ja
Filing date
Publication date
Priority claimed from JP2013509287A external-priority patent/JP6177687B2/ja
Application filed filed Critical
Publication of JP2017131682A publication Critical patent/JP2017131682A/ja
Priority to JP2019113597A priority Critical patent/JP6987811B2/ja
Publication of JP2017131682A5 publication Critical patent/JP2017131682A5/ja
Application granted granted Critical
Publication of JP6891010B2 publication Critical patent/JP6891010B2/ja
Priority to JP2021194048A priority patent/JP7358441B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017050041A 2010-05-07 2017-03-15 実質組織からの細胞の移植方法 Expired - Fee Related JP6891010B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2019113597A JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法
JP2021194048A JP7358441B2 (ja) 2010-05-07 2021-11-30 膵臓に細胞を移植するための薬剤の製造のための混合物の使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33244110P 2010-05-07 2010-05-07
US61/332,441 2010-05-07
JP2013509287A JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2013509287A Division JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019113597A Division JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法

Publications (3)

Publication Number Publication Date
JP2017131682A JP2017131682A (ja) 2017-08-03
JP2017131682A5 true JP2017131682A5 (enExample) 2019-08-08
JP6891010B2 JP6891010B2 (ja) 2021-06-18

Family

ID=44902076

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2013509287A Expired - Fee Related JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用
JP2017050041A Expired - Fee Related JP6891010B2 (ja) 2010-05-07 2017-03-15 実質組織からの細胞の移植方法
JP2019113597A Expired - Fee Related JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法
JP2021194048A Active JP7358441B2 (ja) 2010-05-07 2021-11-30 膵臓に細胞を移植するための薬剤の製造のための混合物の使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2013509287A Expired - Fee Related JP6177687B2 (ja) 2010-05-07 2011-05-06 実質組織からの細胞の移植用医薬の製造に用いられる混合物の使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2019113597A Expired - Fee Related JP6987811B2 (ja) 2010-05-07 2019-06-19 細胞の凍結保存方法
JP2021194048A Active JP7358441B2 (ja) 2010-05-07 2021-11-30 膵臓に細胞を移植するための薬剤の製造のための混合物の使用

Country Status (19)

Country Link
US (1) US20110274666A1 (enExample)
EP (1) EP2566567A4 (enExample)
JP (4) JP6177687B2 (enExample)
KR (4) KR102230864B1 (enExample)
CN (2) CN102985130A (enExample)
AR (1) AR081906A1 (enExample)
AU (1) AU2011247984B2 (enExample)
BR (1) BR112012028265B1 (enExample)
CA (2) CA3146949A1 (enExample)
CL (1) CL2012003085A1 (enExample)
CR (1) CR20120603A (enExample)
IL (3) IL222857A (enExample)
MX (3) MX359678B (enExample)
NZ (2) NZ603913A (enExample)
PH (1) PH12012502176A1 (enExample)
RU (1) RU2736955C2 (enExample)
SG (2) SG185425A1 (enExample)
TW (3) TW201202424A (enExample)
WO (1) WO2011140428A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10865383B2 (en) 2011-07-12 2020-12-15 Lineage Cell Therapeutics, Inc. Methods and formulations for orthopedic cell therapy
US8961617B2 (en) * 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US9533013B2 (en) * 2013-03-13 2017-01-03 University Of North Carolina At Chapel Hill Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree
EP2886644A1 (en) * 2013-12-20 2015-06-24 Kallistem Process for implementing in vitro spermatogenesis and associated device
US10765705B2 (en) 2014-11-24 2020-09-08 Prime Merger Sub, Llc Visco-supplement compositions, and methods of use thereof
US20160213714A1 (en) * 2015-01-23 2016-07-28 Everon Biosciences, Inc. Induction of cellular senescence for tissue therapies
CN106148266A (zh) * 2015-04-20 2016-11-23 烟台赛泽生物技术有限公司 一种免疫细胞用培养基及该培养基的添加剂
JP2016209303A (ja) * 2015-05-08 2016-12-15 レジエンス株式会社 肝組織を再生するための製剤
US20170369849A1 (en) * 2016-05-11 2017-12-28 The University Of North Carolina At Chapel Hill Compositions and methods for bioengineered tissues
WO2018058541A1 (zh) * 2016-09-30 2018-04-05 台北荣民总医院 冷冻处理中保护生物组织的防冻剂及其制备方法
KR20190141168A (ko) * 2017-04-06 2019-12-23 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 동결보존 방법
KR20200028391A (ko) 2017-06-12 2020-03-16 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 세포 생착용 패치 이식편 조성물
KR102955766B1 (ko) 2018-05-03 2026-04-22 콜플랜트 리미티드 진피 충전제 및 이의 적용
JP2020050625A (ja) * 2018-09-27 2020-04-02 株式会社北里コーポレーション 卵巣組織の移植方法および卵胞活性化方法
JP7350505B2 (ja) * 2019-02-15 2023-09-26 イビデン株式会社 生体試料を含む固化体
WO2021060380A1 (ja) * 2019-09-27 2021-04-01 公立大学法人横浜市立大学 肝細胞の可塑性誘導法
AU2022253477A1 (en) * 2021-04-09 2023-10-12 William Marsh Rice University Interfacial seeding of cells and particles on surfaces for diagnostics and therapeutics
WO2023042875A1 (ja) * 2021-09-16 2023-03-23 富士フイルム株式会社 ゲル形成キット及びその利用
WO2023127872A1 (ja) * 2021-12-28 2023-07-06 株式会社ポル・メド・テック 移植材料の製造方法、及び移植材料
KR20250056904A (ko) * 2022-08-24 2025-04-28 가부시키가이샤 비타 형광 표지용 조성물, 형광 프로브, 주입제, 시린지 충전물, 의료 기구, 의료용 섬유 소재, 형광 표지용 조성물의 제조 방법 및 의료용 섬유 소재의 제조 방법
CN116920263B (zh) * 2023-07-28 2026-04-21 南方医科大学南方医院 一种透皮递送活体干细胞的冷冻微针及其制备方法和应用
CN117426368B (zh) * 2023-10-08 2026-06-16 北京汇智泰康医药技术有限公司 一种肝细胞冻存液及其应用

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6231881B1 (en) * 1992-02-24 2001-05-15 Anton-Lewis Usala Medium and matrix for long-term proliferation of cells
US20040138329A1 (en) * 1992-04-20 2004-07-15 Board Of Regents Of The University Of Texas System Gels for encapsulation of biological materials
CA2140905A1 (en) * 1992-07-29 1994-01-30 Keith E. Dionne Use of pouch of implantation of living cells
US5709854A (en) * 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5681587A (en) * 1995-10-06 1997-10-28 Desmos, Inc. Growth of adult pancreatic islet cells
US6482231B1 (en) * 1995-11-20 2002-11-19 Giovanni Abatangelo Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
WO1997045533A1 (en) * 1996-05-28 1997-12-04 The Regents Of The University Of Michigan Engineering oral tissues
US6224893B1 (en) * 1997-04-11 2001-05-01 Massachusetts Institute Of Technology Semi-interpenetrating or interpenetrating polymer networks for drug delivery and tissue engineering
JP3014343B2 (ja) * 1997-06-06 2000-02-28 科学技術振興事業団 肝細胞の培養方法
IT1293484B1 (it) * 1997-06-11 1999-03-01 Fidia Advanced Biopolymers Srl Materiale biologico comprendente una efficiente coltura di cellule e una matrice tridimensionale biocompatibile e biodegradabile
US6129911A (en) * 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
CA2877233A1 (en) * 1999-01-19 2000-07-27 Lola M. Reid Human liver progenitors
US6592623B1 (en) * 1999-08-31 2003-07-15 Virginia Commonwealth University Intellectual Property Foundation Engineered muscle
US6365385B1 (en) * 1999-03-22 2002-04-02 Duke University Methods of culturing and encapsulating pancreatic islet cells
WO2000066036A2 (en) * 1999-04-30 2000-11-09 Massachusetts General Hospital Fabrication of vascularized tissue using microfabricated two-dimensional molds
US6660905B1 (en) * 1999-07-14 2003-12-09 The Board Of Trustees Of The Leland Stanford Junior University Mice comprising engrafted functional human hepatocytes
US6960576B2 (en) 1999-09-13 2005-11-01 Bristol-Myers Squibb Pharma Company Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production
RU2165263C1 (ru) * 2000-06-23 2001-04-20 Зыбин Дмитрий Владимирович Способ лечения сахарного диабета
US7291673B2 (en) * 2000-06-02 2007-11-06 Eidgenossiche Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US6435190B1 (en) * 2000-06-14 2002-08-20 Syde A. Taheri Autogenous cell patch cardio myoplasty and advanced muscle graft implantation system
MY130475A (en) * 2000-08-25 2007-06-29 Contura As Polyacrylamide hydrogel and its use as an endoprosthesis
CA2430130A1 (en) * 2000-11-28 2002-06-06 Focal, Inc. Polyalkylene glycol viscosity-enhancing polymeric formulations
US20030077566A1 (en) * 2001-09-10 2003-04-24 Palasz Andrzej T. Method for cryopreserving mammalian cells and tissues
US20040191225A1 (en) * 2002-08-06 2004-09-30 Dinsmore Jonathan H. Injection system
US7319035B2 (en) * 2002-10-17 2008-01-15 Vbi Technologies, L.L.C. Biological scaffolding material
WO2004098285A2 (en) * 2003-05-08 2004-11-18 Cellartis Ab Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
RU2006110526A (ru) * 2003-09-02 2007-10-10 Юниверсити Оф Норт Каролина Эт Чепел Хилл (Us) Биодеградируемые конъюгаты полимер-лиганд и их применение для выделения клеточных субпопуляций и для криоконсервации, кульоконсервации, культивирования и трансплантации клеток
WO2005028640A1 (en) * 2003-09-19 2005-03-31 Newsouth Innovations Pty Limited Method for isolating hepatocytes
US20080176205A1 (en) * 2003-12-04 2008-07-24 University Of Utah Research Foundation Process and Formulation to Improve Viability of Stored Cells and Tissue
US7884185B2 (en) * 2004-07-28 2011-02-08 University Of Delaware Hydrogels and uses thereof
US8828433B2 (en) * 2005-04-19 2014-09-09 Advanced Cardiovascular Systems, Inc. Hydrogel bioscaffoldings and biomedical device coatings
RU2008124158A (ru) * 2005-11-16 2010-01-10 Юниверсити Оф Норт Каролина Эт Чепел Хилл (Us) Внеклеточные матриксные компоненты для экспансии и дифференцировки гепатических клеток-предшественников
CA2653905A1 (en) * 2006-05-30 2007-12-06 Julio De La Fuente Martinez Procedure for the preparation of unilamellar vesicles for cryopreservation and the culture of stem cells and embryos
TW200817019A (en) * 2006-07-10 2008-04-16 Univ Columbia De novo formation and regeneration of vascularized tissue from tissue progenitor cells and vascular progenitor cells
CA2663722C (en) * 2006-09-21 2014-12-09 Purdue Research Foundation Collagen preparation and method of isolation
US20080233088A1 (en) * 2007-02-16 2008-09-25 Varian Medical Systems Technologies, Inc. Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation
CN101855340A (zh) * 2007-03-06 2010-10-06 北卡罗来纳大学查珀尔希尔分校 用于细胞维持、扩增和/或分化的透明质酸、其他基质成分、激素和生长因子的复合物
US20080311045A1 (en) * 2007-06-06 2008-12-18 Biovaluation & Analysis, Inc. Polymersomes for Use in Acoustically Mediated Intracellular Drug Delivery in vivo
TW200916581A (en) * 2007-06-15 2009-04-16 Univ North Carolina Paracrine signals from mesenchymal feeder cells and regulating expansion and differentiation of hepatic progenitors using same
GB0713079D0 (en) * 2007-07-05 2007-08-15 Ucl Business Plc biomaterial scaffolds with defined stiffness
CA2695971A1 (en) * 2007-08-15 2009-02-19 Ramot At Tel Aviv University, Ltd. Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair
EP2190562A2 (en) * 2007-08-20 2010-06-02 Do-Coop Technologies Ltd Enriched nanostructure composition
EP3338549A1 (en) * 2007-11-20 2018-06-27 Pioneer Surgical Orthobiologics, Inc. Cryopreservation of cells using cross-linked bioactive hydrogel matrix particles
CN101618235A (zh) * 2008-07-01 2010-01-06 中国人民解放军军事医学科学院基础医学研究所 一种基于opf水凝胶为液态支架的可注射性心肌组织工程产品
EP2341953B1 (en) * 2008-09-04 2018-11-21 The General Hospital Corporation Hydrogels for vocal cord and soft tissue augmentation and repair
US20100092533A1 (en) * 2008-10-15 2010-04-15 Joshua Stopek Bioabsorbable Surgical Composition
EP2221362A1 (en) * 2009-02-19 2010-08-25 Naturin GmbH & Co Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies

Similar Documents

Publication Publication Date Title
CL2012002882A1 (es) Compuestos derivados de 5,7- sustituido -imidazol [1,2-c] pirimidinas, inhibidores de jak-quinasa; proceso de preparacion; composicion farmaceutica; y su uso para tratar una enfermedad autoinmunitaria o inflamatoria, el rechazo de transplante de organos, tejidos o celulas en un mamifero.
WO2009115581A3 (en) Improved cryopreservation of adipose tissue for the isolation of mesenchymal stem cells
WO2012021845A3 (en) Improved hematopoietic stem and progenitor cell therapy
WO2011117258A3 (en) Methods of increasing efficiency of vector penetration of target tissue
BRPI0813729B8 (pt) métodos de preparação de massas celulares de cardiomiócitos purificados derivados de células-tronco pluripotentes e de uma película de massas celulares de cardiomiócitos, bem como dispositivo médico e uso das referidas massas celulares
JP2018518943A5 (enExample)
WO2016070166A3 (en) Messenger una molecules and uses thereof
CL2009001476A1 (es) Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular.
JP2014501518A5 (enExample)
EA201890137A1 (ru) Среда для культивирования клеток с добавлением таурина и способы применения
WO2017105565A3 (en) Compositions for therapeutics, targeted pet imaging and methods of their use
EP4692350A3 (en) Compositions and methods for induced tissue regeneration in mammalian species
EP1910519A4 (en) IMMUNOPHÄNOTYP AND IMMUNOGENICITY OF HUMAN CELLS FROM FAT TISSUE
NZ630598A (en) Method of engrafting cells from solid tissues
MX2021012041A (es) Metodos para promover la diferenciacion de celulas epiteliales timicas y progenitores de celulas epiteliales timicas de celulas madre pluripotentes, celulas resultantes y usos de estas.
IL260210B2 (en) cftr regulators and methods of using them
WO2016191179A8 (en) In vitro models of regenerative muscle cell therapy and uses thereof
MX373950B (es) USO DE UN INHIBIDOR TEMPORAL DE UN GEN p53 PARA LA PROFILAXIS DE LESIÓN POR ISQUEMIA-REPERFUSIÓN.
BR112012030015A2 (pt) composição para a preservação de órgãos a frio, método para a preparação de uma composição de preservação de órgãos a frio, uso da cardiotrofina-1 ou uma variante equivalente funcionalmente da mesma, método para a preservação de órgãos a frio, órgão isolado preservado a frio e kit para a preparação de uma composição para a preservação de órgãos a frio
JP2016510766A5 (enExample)
WO2006107850A3 (en) Preventing rejection of transplanted tissue using regulatory t cells
CY1112746T1 (el) Κρυοσυντηρηση ηπατοκυτταρων
EP3543331A4 (en) CELL POPULATION CONTAINING MESENCHYMAL STEM CELLS DERIVED FROM F RATE APPENDICES, METHOD FOR PRODUCING THE SAME, AND MEDICINAL COMPOSITION
JP2010166901A5 (enExample)
RU2011103549A (ru) Предшественник искусственной почки и способ его получения